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An introduction to epithelial cell surface polarity and cAMP-dependent protein kinase A
The ability of cells to establish a polarized phenotype, which includes an anisotropic organisation and asymmetry of their plasma membranes, is fundamental for organism development and functioning. While this includes many cell types including (migrating) fibroblasts, one of the best studied cases of cell surface asymmetry is that exhibited by the epithelium, one of the four primary body tissues. Epithelial cells line most body cavities and display structurally and functionally distinct cell surface domains (1) . These include apical and basolateral surface domains which face the body exterior and underlying tissue, respectively (figure 1A). Apical and basolateral cell surface domains differ in protein and lipid composition, a feature that is vital for these cells to perform domain-specific functions such as the selective uptake and excretion of molecules and protection of the body against pathogens and toxic compounds. Cell surface polarity is generated and maintained in spite of continuous exo-, endo-, and transcytotic membrane fluxes between these domains and intracellular organelles (figure 1A). The intracellular sorting of newly synthesized and recycling proteins and lipids is therefore crucial to generate and maintain such specific plasma membrane compositions, as well as to tailor these to meet changing physiological needs (2, 3) . Predominant sorting stations for basolateral and apical plasma membrane components in epithelial cells are provided by the Golgi apparatus and/or the recently identified subapical compartment/ common recycling endosome (4) (5) (6) ( Figure 1A ).
Cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) have emerged as key signaling molecules that regulate the intracellular sorting and trafficking of basolateral and apical membrane components and, consequently, are involved in the functional dynamics of epithelial cell surface domains, in response to extracellular cues. For example, in the renal collecting duct, the reabsorption of water is regulated by the antidiuretic hormone vasopressin which, upon binding to its receptor on the basolateral surface of kidney epithelial cells stimulates cAMP production and the PKA-mediated trafficking of water channels from the Golgi apparatus and/or endosomes to the apical membrane, thereby allowing water reabsorption from the pro-urine (7) (figure 1B). In the entero-hepatic circulation, peptide hormones that are secreted following a meal increase cAMP production in hepatocytes leading to increased PKA-mediated trafficking of ABC transporters from the Golgi apparatus and/or endosomes to the apical, bile canalicular domain. This stimulates the secretion of bile acids that, in turn, can help digest fats in the intestinal apical lumen (8) (figure 1B). One of the most important questions in this research field is how PKA activation, elicited by various extracellular stimuli, produces specific effects on the dynamics of distinct and spatially separated intracellular membrane systems. To address this question, insight in the structural and spatial-temporal dynamics of cAMP-PKA complexes is crucial.
In mammalian cells, PKA is a holoenzyme (9) which consists of two regulatory and two catalytic subunits. Four different regulatory subunits are distinguished, RIα, RIβ, RIIα, and RIIβ, the expression of which is tissue-dependent and developmentally regulated by a protein kinase A inhibitor called PKI. Regulatory subunits of PKA bind to free catalytic subunits (α, β, γ, or PRkX) and their primary function appears to keep the catalytic subunits in an inactive state. Two molecules of cAMP, which is produced by any of the nine known mammalian adenylyl cyclases in response to activation of G proteins coupled to different membrane receptors, bind to each regulatory subunit of PKA and causes the subsequent release and activation of the catalytic subunits (10, 11) .
These, in turn, can phosphorylate target proteins at serine and threonine residues. 4 cAMP phosphodiesterases (PDEs), which comprise eleven distinct families yielding a multitude of invariably expressed PDE isoforms (12) , play an important part in regulating PKA activity by restricting local cAMP levels. In addition to the control of local cAMP concentrations by adenylyl cyclase and PDEs, a family of more than fifty A-kinase anchoring proteins (AKAPs) (13) control the spatial distribution of the different PKA holoenzymes and, thereby, focuss their access to substrate proteins.
AKAPs interact with dimers of PKA regulatory subunits with a high but varying affinity (14) and anchor RII subunits at among others the nucleus, cytoskeleton, organelle membranes, and plasma membrane (15) (16) (17) . While most AKAPs anchor RII subunits, so-called dual AKAPS have recently been identified which also anchor RI subunits. These include D-AKAPs at the endoplasmic reticulum and mitochondria (18) , and BIG1 and BIG2 at the Golgi apparatus and recycling endosomes (19) .
Most
AKAPs also contain regions for binding additional enzymes, e.g. PDEs, adenlyl cyclase, protein phosphatases, and other kinases (20) (21) . As unique signaling platforms AKAPs thus can create regulatory networks that ensure the coordinated propagation of PKA signals through different locations in the cell. Such a coordinated signal propagation may be of particular importance in directing the sequential steps involved in the sorting and vesicular trafficking of proteins and lipids through the cells, often bridging many micrometers. Indeed, AKAPs and PKA isoforms are found at many organelles that mediate the intracellular sorting and trafficking of membrane proteins and lipids, e.g. the microtubule-organizing center (MTOC) or centrosome (22) , cytoskeleton (23) , the plasma membrane (24) , Golgi apparatus (19, 25) and endoplasmic reticulum (18) (figure 2A ), sometimes complexed with cargo proteins (see below). In the following sections, we will review the literature with regard to the role of
The role of cAMP/PKA in exocytosis
The polarization of exocytosis is a fundamental mechanism for the targeted secretion of molecules and to localize plasma membrane components to specific regions of the cell surface in order to establish, maintain, and/or tailor functional cell surface domains. Elevation of the intracellular cAMP concentration enhances exocytic transport of proteins to the apical surface in among others pancreatic β-cells (26) , kidney (27, 28) , intestine (29, 30) , hepatic (31, 32) , and principal (33) (34) (35) epithelial cells. A similar process is observed in neurons, where a rise in intracellular cAMP concentration enhances exocytic transport to and neurotransmitter release at the axonal synapse (36, 37) , the latter being considered the equivalent of the epithelial apical surface domain. Most of the effects of cAMP are mediated by PKA, although some are mediated by other cAMP effectors such as Epac, a guanine nucleotide exchange factor for the small GTPase Rap1, or calcium channels (38) . While the cAMP/PKA system in mammalian cells is highly redundant with multiple genes encoding several PKA regulatory and catalytic subunits (see paragraph above), Drosophila have a single or predominant gene encoding the PKA catalytic subunit, DC0, which is preferentially expressed in mushroom bodies in the brain (39) . Drosophila DC0 mutants which lack PKA catalytic activity show defects in neurotransmitter release in response to extracellular cues including cAMP (40, 41) , and display learning and memory deficits (39, 42, 43) , underscoring the involvement of PKA in the dynamics of the axonal surface and synaptic plasticity. Excellent review articles have recently addressed the role of cAMP/PKA in regulating exocytosis in neurons in relation to synaptic plasticity, learning, and memory (44, 45) . Here we will focus on epithelial cells. (46) . A similar phenomenon is observed in hepatocytes stimulated by glucagon which activates adenylyl cyclase activity and cAMP production (47) . In accordance with those observations, H89, an inhibitor that also inhibits the activity of the catalytic subunit of PKA, perturbs intracellular trafficking of apical secretory proteins, as shown for instance in lacrimal cells (48) . It has been proposed that cAMP modulates the rate of 'constitutive' exocytosis (31) , showing little specificity for the different apical membrane components. This may suggest that cAMP/PKA targets molecular machineries that control vesicular membrane flow in general. However, as will be discussed in the next paragraph, there are also examples in which PKA controls the intracellular flow of specific 'cargo' proteins and lipids.
The involvement of cAMP/PKA signaling in the apical exocytosis of specific proteins has mostly focused on polytopic membrane transporter proteins. These include aquaporins, a class of integral membrane proteins that form water channels in the plasma membrane to selectively conduct water molecules, and important for the functioning of all fluid-transporting epithelia. In Madin-Darby canine kidney (MDCK) epithelial cells, PKA activity is required for the apical trafficking of vasopressin-controlled aquaporin (AQP)2 (49) . AQP2 possesses a single consensus cAMP-dependent PKA phosphorylation site at Ser256. PKA phosphorylation modulates its distribution between plasma membrane and intracellular vesicular compartments (50, 51) . The role of PKA-mediated phosphorylation of AQP2 at Ser256 is somewhat obscured by the notion that AQP2 transition in the Golgi apparatus is 8 associated with a PKA-independent increase in AQP2 phosphorylation at Ser256, probably mediated by Golgi-associated casein kinase 2 (52) . In renal collecting duct principal cells, cAMP/PKA-induced AQP2 translocation is sensitive to Ht31, a peptide that binds with high affinity to PKA type II regulatory subunits and in this way displaces the PKA-RII holoenzyme from its subcellular anchoring sites (37) . A similar sensitivity of exocytosis to HT31 was earlier demonstrated for the cAMPresponsive insulin secretion in clonal beta cells in response to the insulinotropic hormone glucagon-like peptide 1 (53) . Localized activity of PKA type II at AQP2-bearing vesicles thus appears responsible for the efficient trafficking of AQP2 to apical surface (37) . Interestingly, PKA-RIIα is part of a multi-protein signalling complex located at endosomal membranes in inner medullary collecting duct (IMCD) cells (54) . In this study, AQP2 is shown to be a substrate for protein phosphatase 2B
which, in conjunction with PKA, is responsible for the phosphorylation status that controls AQP2 trafficking and steady state distribution. In addition, PDE4D interacts with PKA-RII on AQP2-bearing vesicles, and is activated in a PKA-dependent manner upon translocation of these vesicles to the apical cell surface to reduce osmotic water permeability (55) . The responsible AKAP that mediates PKA-RIIregulated AQP2 translocation in renal collecting duct principal cells is AKAP18delta (56, 57) . Although the consensus PKA phosphorylation site at Ser256 in AQP2 is clearly important for the subcellular distribution of AQP2, the mechanism by which phosphorylation of AQP2 by PKA controls its intracellular trafficking remains unclear. For instance, it remains to be verified that PKA type II, anchored to AKAP18delta in endosomal membranes, is responsible for the phosphorylation of AQP2 at Ser256. It can be speculated that phosphorylation of AQP2 masks or unmasks a signal that is recognized by molecular machineries that prevent or promote apical surface delivery, respectively, similar as proposed for the adhesion protein NgCAM (58) .
In addition to controlling the apical exocytosis of aquaporins, PKA-RIIα anchoring controls the efficient trafficking of the polytopic multidrug resistance protein MDR-1 (or ABCB1) from the Golgi apparatus to the apical bile canaliuclar surface of hepatocytes, the prime epithelial cells of the liver (59) . At the apical surface of hepatocytes, MDR-1 is necessary for the formation of bile and to reduce the body load of potentially harmful compounds (60) . Wojtal et al. (59) displaced PKA-RIIα from
Golgi-associated AKAPs in human hepatocytes using the small interfering AKAP-IS peptide designed by Scott and colleagues (61) . (59) . Because of the known interrelation between glycosphingolipids and MDR1 (62) , it is proposed that the mistargeting of glycosphingolipids may be responsible for the delay in MDR1 exocytosis (59) .
As a final example, activation of PKA enhances the apical surface-directed transport of the cystic fibrosis transmembrane conductance regulator (CFTR) (63) (64) .
CFTR activity functionally correlates to the interaction of PKA-RII with unspecified but Ht31 peptide-sensitive AKAPs (65) . Also, the direct phosphorylation of CFTR by PKA affects its intracellular trafficking (66, 67) and cAMP increases CFTR expression (67) . Taken together, the evidence indicates that PKA-RII anchoring and activity at endosomes and organelles of the secretory pathway control the proper trafficking and, consequently, the steady state distribution of select polytopic apical plasma membrane transporter proteins.
In addition to regulating the trafficking of specific 'cargo' proteins and lipids as described in the paragraph above, PKA targets molecular machineries that control vesicular membrane flow in general. For instance, PKA activity influences the rate of membrane vesiculation at the Golgi apparatus by stimulating the scission of membrane transport vesicles (68) (figure 2B). It has been proposed that PKA-RIIα controls this process and that the interaction of PKA-RIIα subunits with Golgi cisternae is modulated by trimeric G proteins (69) . Increased PKA activity (isoform not specified) triggers the redistribution of the ADP-ribosylating factor Arf1 from cytosol to trans-Golgi membranes in a cell-free assay, and this is abolished with PKA inhibitory peptides or when cytosol is depleted of PKA catalytic subunits (70) . Two
Golgi-associated Arf-activating proteins, the Brefeldin A-inhibited guanine nucleotide-exchange proteins (GEPs) BIG1 and BIG2, are both AKAPs (19) . Elevation of cAMP caused PKA-catalyzed phosphorylation of the BIGs and, in an in vitro assay, recombinant PKA altered their GEP activity (71) . The involvement of PKA in Golgi membrane dynamics was recently supported by the notion that the cell-wide downregulation of PKA-RIIα subunits by siRNA results in severe perturbation of Golgi morphology (72) . Protein phosphorylation mediated by PKA affects Golgi morphology in yeast via phosphorylation of the t-SNARE (soluble N-ethylmaleimidesensitive fusion protein attachment protein receptors) protein Sed-5, which controls membrane fusion (73) . Also in mammalian cells, several potential targets of PKA involved in vesicular trafficking act in membrane fusion. In polarized neurons for example, these include syntaphilin, a protein interacting with dynamin-1 and syntaxin-1 which, in turn, regulate the scission and fusion of secretory vesicles, respectively, at the axonal synapse (the neuronal equivalent of the epithelial apical plasma membrane domain (74) ). The phosphorylation of syntaphilin by PKA on Ser43 in isolated rat brain synaptosomes or syntaphilin-transfected HEK293 cells inhibits its interaction with dynamin-and syntaxin-1 (75) , and annuls its inhibitory effect on synaptic vesicle exocytosis ( figure 2B ). In cultured superior cervical ganglion neurons, PKA phosphorylates tomosyn which, like synthaphilin, is a member of SNARE regulatory protein family that limits synaptic transmission. Thus, PKAmediated phosphorylation of tomosyn reduces its inhibitory interaction with syntaxin-1 and promotes SNARE assembly, exocytic vesicle fusion, and the release of neurotransmitters in response to a potent biological mediator, the pituitary adenylate cyclase-activating polypeptide (26) . Other molecular targets of PKA implicated in exocytosis include cystein string protein, rabphilin 3A, αSNAP (N-ethylmaleimide sensitive factor attachment protein), snapin, SNAP-25 and syntaxin 4 (38, 76) . The PKAmediated phosphorylation of these proteins changes their respective protein-protein interactions and, in this way, modulates the vesicle priming and/or fusion stages of exocytosis. PKA may thus control exocytosis at different steps of the pathway, e.g.
vesicle budding and scission from the donor membrane such as the Golgi apparatus or endosomes, and vesicle fusion with the target (plasma) membrane.
The cytoskeleton network, including actin filaments and microtubules, are instrumental in directing transport vesicles to defined subcellular sites (77) .
Cytoskeleton-associated AKAPs have been reported (23) . PKA regulatory subunits form complexes with dynein, and with kinesin II and myosin V, and in this way control the spatial organisation of pigment granules in melanophores (78) . Also the epinephrine-induced clustering of secretory Weibel-Pallade bodies in endothelial cells involves a PKA-dependent regulation of the dynein-dynactin complex (79) , and inhibition of PKA-RII anchoring in human hepatoma cells results in a (non-polar)
repositioning of the centrosome and surrounding recycling endosomes (80) . In the latter study, surprisingly, inhibition of catalytic PKA activity did not alter the position of the centrosome and recycling endosomes. It thus appears that regulatory PKA subunits, through their interaction with cytoskeleton motor proteins, can control the spatial distribution of secretory organelles. Whether and how this may influence the movement of transport vesicles remains to be investigated.
The role of cAMP/PKA in endocytosis
Besides stimulating exocytosis, activation of the cAMP-dependent second messenger pathway causes a significant reduction in endocytosis in epithelial T84 cells as measured by uptake of fluid-phase markers (81) . Furthermore, cAMP stimulates the exocytosis of CFTR but at the same time inhibits its apical endocytosis (82, 83) . In case of AQP2, PKA-mediated phosphorylation of Ser256 not only stimulates exocytosis of the water channel, but is also required for its subsequent reinternalization (84) . This and other data underscore that the process of exocytosis is closely correlated to the endocytosis of membrane components, which provides an efficient way of controlling the size and composition of plasma membrane domains and, therefore, functional cell surface polarity. Perhaps therefore not surprisingly, there are numerous reports implicating PKA as a regulator of the endocytic process. In some instances, PKA directly phosphorylates the 'cargo' protein. Indeed, the low density lipoprotein-related protein LRP is phosphorylated by PKA at Ser76, and mutations of Ser76 result in a decrease in the initial endocytosis rate of LRP and a lower efficiency in delivery of ligand for degradation (85) . While PKA activity may promote the endocytosis of LRP, the agonist-stimulated endocytosis of glutamate receptors is inhibited by PKA activation, which may reduce the interaction of glutamate receptors with G-coupled receptor kinase 2 and arrestins (87) . Interestingly, inhibition of basal PKA activity induces clathrin-mediated endocytosis of unoccupied, inactive epidermal growth factor receptors (EGFR) and its accumulation into early endosomes without affecting the endocytosis of transferrin and µ-opioid receptors. It is proposed that the predominant distribution of inactive EGFR at the plasma membrane involves a PKAdependent restrictive condition resulting in receptor avoidance of endocytosis until it is bound and activated by a ligand (86) . PKA may control endocytosis by associating 14 with compositionally and biophysically distinct plasma membrane domains. For instance, the PKA catalytic subunit interacts with caveolin-1, a key component of caveolar membranes domains (88) , and PKA-mediated phosphorylation triggers the agonist-induced internalization of G-protein coupled beta1-adrenergic receptors via a caveolar pathway in non-polarized cells (89) . PKA also controls protein recycling to the plasma membrane following endocytosis. For instance, AKAP79, which interacts with a PDZ domain in the beta1-adrenergic receptor, mediates the targeting of PKA-RII to these receptors, and their subsequent PKA-mediated phosphorylation promotes recycling of the receptors from endosomal membranes back to the plasma membrane and, in this way, the functional resensitization of the receptor (90) . Whether AKAPs, PKA, and receptors traffic as a complex and whether they can, in this way, direct their transit through the heterogeneous endosomal membrane system (as suggested by Stefan et al.,
) remains to be investigated. In addition to the role of PKA in setting the trafficking itinerary of beta1-adrenergic receptors, AQP-4 in human gastric cells is phosphorylated by PKA subsequent to its endocytosis from the basolateral surface, and it is suggested that this phosphorylation is involved in retaining AQP4 in an endosomal recycling compartment (91) . Downstream in the endocytic pathway, PKA-RIIα regulates membrane traffic between endosomes and the Golgi apparatus and plays a pivotal role in endosome-to-Golgi transport of the plant toxin ricin upon stimulation with cAMP analogues (92) . A similar stimulating effect is observed in case of retrograde transport of these proteins from the Golgi apparatus to the endoplasmic reticulum, where the toxin is eventually translocated to the cytosol where it blocks protein synthesis. In concert, overexpression of PKA-RIIα sensitizes cells to ricin.
Intriguingly, non-hydrolyzable cAMP analogues stimulate non-clathrin-mediated endocytosis of ricin from the apical but not basolateral surface to the Golgi apparatus in MDCK cells (93) , suggesting that PKA-RIIα discriminates between different, i.e.
apical versus basolateral populations of endosomes, and/or affects different endocytic pathways in different cell types.
Also PKA-RI localizes to endosomes. The RIα subunit of PKA was found to localize on Rab7-positive late endosomes and on microtubule-associated protein light chain 3-positive autophagosomes in cultured cells. RIα was also shown to physically interact with the mTOR (mammalian target of rapamycin) kinase and affect its phosphorylation and activity (94) . While the regulation of autophagocytosis by cAMP levels is highly conditional (95) , . PKA is implicated in cholesterol and caveolae-controlled transcytosis of basolaterally localized high-density lipoprotein scavenger receptor class B type I (SR-BI), in MDCK cells (30) . In this study, a scenario is proposed in which cholesterolbased membrane microdomains, or rafts, promote internalization and basolateral recycling of internalized SR-BI whereas a PKA pool sensitive to cholesterol depletion mediates SR-BI transcytosis (30) . The exact intracellular location at which PKA promotes SR-BI transcytosis is not clear. However, a switch from basolateral recycling to apical transcytosis of membrane components typically occurs in the endosomal system. This has been clearly demonstrated in polarized hepatocytes. In these cells, cAMP/PKA activates an apical surface-directed pathway exiting from a subapical compartment/ common recycling endosome (SAC/CE), and changes the trafficking of the fluorescently labelled sphingolipid analogues C6-NBDsphingomyelin and -galactosylceramide from a apical-to-SAC/CE-to-basolateral itinerary to a apical-to-SAC/CE-to-apical pathway (96, 97) . The activated SAC/CE-toapical pathway represents the final leg in the basolateral to apical transcytotic route (90) . Indeed, the SAC/CE connects basolateral and apical endocytic routes and thus takes a prominent position in the transcytotic pathway (5, 98, 99) . The PKA inhibitor H89
prevents the cAMP/PKA-induced apical flow of the fluorescent lipids from the SAC/CE as well as that of transcytosing proteins (100) . By contrast, the constitutive apical recycling of C6-NBD-glucosylceramide from the SAC/CE is unaffected by PKA inhibition (100) . Importantly, the stimulatory effect of cAMP/PKA on the apicaldirected flow of the sphingomyelin analogues from the SAC/CE strongly coincides with enhanced development of apical plasma membrane domains, suggesting that PKA-stimulated trafficking from the SAC/CE (i.e. the last step of the transcytotic pathway) and the biogenesis of apical plasma membrane domains are intimately , and reduced and elevated levels of sphinganine promote and inhibit apical surface development, respectively.
As a part of the underlying mechanism, dihydroceramide synthase activity and ensuing low sphinganine levels are required for cAMP/PKA-mediated activation of the apical-surface-directed trafficking pathway from the SAC/CE (101) . Interestingly, a sphingosine kinase-interacting protein, SKIP, which mediates the phosphorylation of sphingoid bases, anchors PKA (102) ; supporting the notion that sphingoid base metabolism may be regulated by PKA.
The correlation between PKA-stimulated trafficking from the SAC/CE and the biogenesis of apical plasma membrane domains is further corroborated by the observation that the interleukin 6 family cytokine oncostatin M (OSM), an important factor in fetal liver development, stimulates apical plasma membrane biogenesis in hepatocytes in a PKA-dependent manner (103) . Stimulation of hepatocytes with OSM does not elevate cAMP levels or stimulate overall PKA activity but enhances the association of PKA-RIIα with centrosomes in an ERK1-dependent manner (80, 103) . 18 Displacement of PKA-RIIα from the centrosome, by means of a small interfering peptide (80) or by forcing synchronised hepatocytes into the S-phase of the cell cycle (104) , prevents the stimulatory effect of OSM on apical membrane biogenesis. Given that OSM stimulates PKA-dependent membrane transport exiting from the SAC/CE to promote apical membrane biogenesis (103) , the recruitment of PKA-RIIα at the centrosome may be an important factor in the regulation of polarized, apical surfacedirected membrane trafficking from the SAC/CE in response to extracellular cytokines. However, this remains to be investigated. holoenzyme-specific cAMP analogues (105) , In vivo assays that measure the interaction of specific regulatory and catalytic subunits as a mesasure for PKA holoenzyme-specific activity (105) , and peptide-based disruptors of specific PKA-AKAP interactions (61; 106-109) , used in combination with established biochemical and (live) cell biological assays, is expected to boost our understanding of the role of PKA signaling in membrane dynamics and the plasticity of cell surface domains, and the life-facilitating processes that are so critically dependent thereof. 
Conclusions and perspectives

